Poland· PL-100111972

Arava

A leflunomid product containing leflunomidum, registered in Poland by Sanofi-Aventis Deutschland GmbH. The same ATC class is registered in 4 of our 19 countries.

ATC L04AA13

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about leflunomidumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Leflunomid is registered in 4 of 19 countries.

Countries holding a registration under ATC L04AA13 (leflunomid), each read from that country’s own register.

This record: Poland, from URPL (Poland)
3 of them publish a price we can compare per daily dose

Search leflunomid products by name

Leflunomid · ATC L04AA13

4 / 19 countries

Belgiumprice
Ireland
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)

Active substance: Leflunomidum
Manufacturer: Sanofi-Aventis Deutschland GmbH
Country: Poland (PL)
ATC code: L04AA13
ATC class: Leflunomid
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 7

3 priced

gtin
05909990977918
gtin
05909990977925
30 szt.
PLN 120.38
gtin
05909990977932
gtin
05909990977949
gtin
05909990977956
gtin
05901878600482
30 szt.
PLN 109.39
gtin
05903792743399
30 szt.
PLN 109.45

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

805 interactions on record for leflunomid.

Graded by severity as the source publishes them — 537 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check leflunomid against other medicines How interaction checks work

Leflunomid · interactions on record

805 records

537 severe
47 moderate
7 minor
214 info

Most severe, free to view

ClotrimazoleA01AB18severe
Chenodeoxycholic acidA05AA01severe
PrednisoloneA07EA01severe
HydrocortisoneA07EA02severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Leflunomid in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All leflunomid products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Leflunomid Stada
Belgium · Leflunomid Sandoz, Leflunomide Ab
Bulgaria · Багеда
Cyprus · Arotan
Czechia · Leflon, Leflugen
Germany · Leflon, Leflunomid 1 A Pharma
Denmark · Leflunomid, Leflunomid "egis"
Estonia · Leflunomide Elvim
Spain · Lefluartil, Leflunomida Aurovitas
Finland · Leflunomide Orion, Leflunomide Stada
France · Leflunomide Arrow, Leflunomide Biogaran
United Kingdom (Northern Ireland) · Leflunomide Aspire Pharma, Leflunomide Milpharm
Greece · Lefid, Lefluonia
Hungary · Leflunomid Sandoz
Ireland · Leflunomide Aspire Pharma (Malta)
Iceland · Arava, Leflunomide Medac
Italy · Leflunomide Aurobindo, Leflunomide Mylan
Liechtenstein · Arava, Leflunomide Medac
Lithuania · Leflunomide Elvim, Leflunomide Sandoz
Latvia · Leflunomide Elvim, Leflunomide Sandoz
Malta · Leflunomide Normon
Netherlands · Leflunomide Aurobindo, Leflunomide Cf
Norway · Arava, Leflunomide Medac
Portugal · Leflunomida Farmoz, Leflunomida Generis
Romania · Leflon, Leflunomidă Arena
Sweden · Leflunomid Bluefish

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/493a24cd-7d08-4590-b45f-e8ebf0962af7
GET /v1/drugs/493a24cd-7d08-4590-b45f-e8ebf0962af7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "20 mg",
  "packaging": "05909990977918 ¦ Rpz ¦ EU/1/99/118/005 ¦ 20097\n30 tabl. w blistrze\n05909990977925 ¦ Rpz ¦ EU/1/99/118/007 ¦ 20098\n30 tabl. w butelce\n05909990977932 ¦ Rpz ¦ EU/1/99/118/006 ¦ 20099\n100 tabl. w blistrze\n05909990977949 ¦ Rpz ¦ EU/1/99/118/008 ¦ 20100\n100 tabl. w butelce\n05909990977956 ¦ Rpz ¦ EU/1/99/118/010 ¦ 21064\n50 tabl. w butelce\n05901878600482 ¦ Rpz ¦ EU/1/99/118/007 ¦ Delfarma Sp. z o.o. ¦ 130079\n30 tabl. w butelce\n05903792743399 ¦ Rpz ¦ EU/1/99/118/007 ¦ InPharm Sp. z o.o. ¦ 131473\n30 tabl.",
  "substance": "Leflunomidum 20 mg",
  "common_name": "Leflunomidum",
  "pl_product_id": "100111972",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}

API reference MCP server Plans

See everything about leflunomid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console